QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Jim Boeheim’s attitude toward statistics tells a lot about how he treated his diagnosis of prostate cancer when he was 56. He readily knows how many wins he’s been part of as basketball coach at Syracuse University – 829. Ask…
Blood loss during any operation can affect the surgeon’s view of and access to the area of concern. It can also affect the recovery time and general “well being” of the patient. A better understanding of the male pelvic blood…
In 2010, the National Comprehensive Cancer Network (NCCN) published revised guidelines for prostate cancer screening. Two of the recommendations are: to perform annual screening for men in ther 40’s with a baseline PSA level greater than 1 and to consider…
Cabaztaxel is a new chemotherapy for prostate cancer recently approved by the FDA. A recent multicenter phase 3 clinical trial showed that cabazitaxel (Jevtana® Injection, Sanofi-Aventis) prolongs survival among patients with castrationresistant prostate cancer whose cancer also progressed following treatment…
This year, Provenge (sipuleucel-T), a form of immunotherapy using some of a patient’s own white blood cells, was approved by the FDA for the treatment of asymptomatic or minimally symptomatic metastatic prostate cancer that is no longer responding to hormonal…
With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO – The Project to End Prostate Cancer – demands an apology for all at risk of the disease from the American Cancer…
Many QUEST readers have asked us to include women’s experiences during their partners’ diagnoses and treatment for prostate cancer. This issue, we start that topic and will continue to print stories in future issues. Deb Kolden couldn’t believe what her…
Hospitalization for fever or infection should be infrequent in prostate biopsies. In our *study (Catalona), 5 of 448 men (1.1%) were hospitalized for fever following a prostate biopsy. Although the number is small, we’d like to know if we could…
In the journey to discover the best diagnostic and treatment methods modern medicine can provide, researchers conduct long-term studies on existing screening practices. The outcomes can clarify practices but also they can confuse and sometimes even mislead the public. Recent…
Dr. Catalona wishes to keep his patients and research participants updated on the findings of his prostate cancer research group by providing brief lay summaries in QUEST. These summaries are from studies prepared by Dr. Catalona and his research…
"*" indicates required fields
